IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,248,000 | -13.8% | 1,382,900 | -0.7% | 0.27% | -23.8% |
| Q2 2022 | $15,371,000 | -84.7% | 1,392,300 | -77.0% | 0.35% | -83.2% |
| Q1 2022 | $100,620,000 | +39.4% | 6,043,219 | +59.9% | 2.10% | +36.9% |
| Q4 2021 | $72,160,000 | +100.1% | 3,780,000 | +158.5% | 1.53% | +91.5% |
| Q3 2021 | $36,058,000 | +37.1% | 1,462,200 | +83.0% | 0.80% | -34.5% |
| Q3 2020 | $26,303,000 | +29.7% | 799,000 | +8.2% | 1.22% | -6.1% |
| Q2 2020 | $20,273,000 | – | 738,547 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |